ALKBH5 has been reported to maintain PD-L1 expression through the ALKBH5-PD-L1 regulatory axis in intrahepatic cholangiocarcinoma while inhibiting T-cell growth and infiltration [141]. This evidence concerns the gene CD274 and cholangiocarcinoma.